Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Angiology
|
May 1, 1991
ACE inhibitors in the elderly
E L Posvar, A J Sedman
Journal of Clinical Pharmacology
|
November 1, 1989
New drugs: first time in man
E L Posvar, A J Sedman
Contraception
|
April 9, 2001
Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol
R A Boyd, E A Zegarac, E L Posvar, et al.
Journal of Clinical Pharmacology
|
October 1, 1994
The temporal effect of food on tacrine bioavailability
D F Welty, P H Siedlik, E L Posvar, et al.
Journal of Clinical Pharmacology
|
December 1, 1990
Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis
R D Swartz, B Starmann, A M Horvath, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1996
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects
D D Cilla, L R Whitfield, D M Gibson, et al.
Journal of Clinical Pharmacology
|
October 1, 1995
Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor
L L Radulovic, D D Cilla, E L Posvar, et al.
Journal of Clinical Pharmacology
|
August 1, 1996
Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects
E L Posvar, L L Radulovic, D D Cilla, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1996
Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure
V Mitrovic, H Mudra, T Bonzel, et al.
Journal of Clinical Pharmacology
|
October 1, 1990
Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis
R A Blum, S C Olson, R K Kohli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Angiology
|
May 1, 1991
ACE inhibitors in the elderly
E L Posvar, A J Sedman
Journal of Clinical Pharmacology
|
November 1, 1989
New drugs: first time in man
E L Posvar, A J Sedman
Contraception
|
April 9, 2001
Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol
R A Boyd, E A Zegarac, E L Posvar, et al.
Journal of Clinical Pharmacology
|
October 1, 1994
The temporal effect of food on tacrine bioavailability
D F Welty, P H Siedlik, E L Posvar, et al.
Journal of Clinical Pharmacology
|
December 1, 1990
Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis
R D Swartz, B Starmann, A M Horvath, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1996
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects
D D Cilla, L R Whitfield, D M Gibson, et al.
Journal of Clinical Pharmacology
|
October 1, 1995
Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor
L L Radulovic, D D Cilla, E L Posvar, et al.
Journal of Clinical Pharmacology
|
August 1, 1996
Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects
E L Posvar, L L Radulovic, D D Cilla, et al.
Clinical Pharmacology and Therapeutics
|
June 1, 1996
Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure
V Mitrovic, H Mudra, T Bonzel, et al.
Journal of Clinical Pharmacology
|
October 1, 1990
Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis
R A Blum, S C Olson, R K Kohli, et al.
Page
of 2